发明名称 |
THERAPEUTIC AGENT FOR ALLERGIC RHINITIS |
摘要 |
Provided is a therapeutic agent capable of treating allergic rhinitis in a safe, simple, and noninvasive manner substantially without side effects and physical distress to patients. Provided is a therapeutic agent for allergic rhinitis for 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) comprising 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of the 5-aminolevulinic acid or the derivative as an active ingredient, and used in ALA-PDT in which light having a wavelength of 400 nm to 700 nm is irradiated; and particularly provided is a therapeutic agent for allergic rhinitis in a locally applied solution form, a water-soluble ointment-dissolved form, a jelly-dissolved form, or the like. The therapeutic agent does not require the conduct of 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD) for detecting a site of protoporphyrin IX (PpIX) accumulation radiating light having a wavelength of 610 nm to 650 nm under irradiation of excitation light having a wavelength of 380 nm to 420 nm before ALA-PDT. |
申请公布号 |
EP2722041(A1) |
申请公布日期 |
2014.04.23 |
申请号 |
EP20120801049 |
申请日期 |
2012.06.15 |
申请人 |
SBI PHARMACEUTICALS CO., LTD.;NATIONAL HOSPITAL ORGANIZATION |
发明人 |
TANAKA, TOHRU;INOUE, KATSUSHI;TAKAHASHI, KIWAMU;ISHII, TAKUYA;NUMATA, TSUTOMU;SHIBUYA, MARIKO;SUZUKI, TAKESHI |
分类号 |
A61K31/197;A61K9/06;A61K9/08;A61K41/00;A61N5/06;A61P11/02;A61P37/08 |
主分类号 |
A61K31/197 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|